Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High versus standard dose vancomycin for osteomyelitis.

Emmanuelle Boffi El Amari1, Albert Vuagnat, Richard Stern

  • 1Department of Medicine, Geneva University Hospital, Switzerland.

Scandinavian Journal of Infectious Diseases
|October 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-stroke flexed elbow deformity management: consensus opinion from an international Delphi expert panel.

Annals of physical and rehabilitation medicine·2026
Same author

Validity and reliability of arthrometer-based measures of the first ray relative and absolute mobility: A cadaveric biomechanical study.

Journal of biomechanics·2026
Same author

High-speed trains versus air transport vectors for mass transfers of critically ill patients: The TRANSCOV cohort study.

PloS one·2026
Same author

Early radiographic loss of intermetatarsal angle correction after single first TMT arthrodesis (Modified Lapidus) versus three-corner TMT arthrodesis.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2026
Same author

[Chopart and Lisfranc sprains : don't miss them].

Revue medicale suisse·2026
Same author

A steady hand in a world of turmoil.

EFORT open reviews·2026
Same journal

Fas-Ligand Mediated Apoptosis in Severe Sepsis and Shock.

Scandinavian journal of infectious diseases·2017
Same journal

Lipopolysaccharide-inducible Gene Expression Profile in Human Monocytes.

Scandinavian journal of infectious diseases·2017
Same journal

Fatal varicella pneumonia.

Scandinavian journal of infectious diseases·2015
Same journal

Wissler's Syndrome Associated with Parainfluenza 2 Infection.

Scandinavian journal of infectious diseases·2015
Same journal

Contamination of smears with "sergentella spiroides".

Scandinavian journal of infectious diseases·2015
Same journal

Recrudescent typhus: fluctuations in titers of complement-fixing and microagglutinating antibodies to rickettsia prowazeki in persons with a history of epidemic typhus.

Scandinavian journal of infectious diseases·2015
See all related articles

High-dose continuous vancomycin infusion (HD-CVI) for osteomyelitis treatment resulted in better outcomes and fewer adverse drug reactions, specifically acute renal failure, compared to standard-dose intermittent vancomycin infusion (SD-IVI).

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Orthopedics

Background:

  • Osteomyelitis treatment requires optimal vancomycin dosing and infusion methods for extended periods.
  • Parenteral vancomycin is crucial for Gram-positive cocci osteomyelitis.
  • Identifying effective and safe vancomycin regimens is essential for patient recovery.

Purpose of the Study:

  • To compare high-dose (HD: 40 mg/kg/d) versus standard-dose (SD: 20 mg/kg/d) vancomycin.
  • To evaluate intermittent vancomycin infusion (IVI) versus continuous vancomycin infusion (CVI).
  • To determine the optimal vancomycin strategy for osteomyelitis treatment outcomes and safety.

Main Methods:

  • Retrospective study of 89 patients with Gram-positive cocci osteomyelitis.
  • Comparison of treatment groups: HD-IVI, SD-IVI, HD-CVI, SD-CVI.

Related Experiment Videos

  • Assessment of treatment outcomes and therapeutic safety, focusing on adverse drug reactions like acute renal failure.

    • Main Results:

    • Significantly more adverse drug reactions (acute renal failure) observed in the intermittent vancomycin infusion (IVI) subgroups (HD-IVI vs SD-IVI, p=0.007).
    • No renal failure cases reported in the high-dose continuous vancomycin infusion (HD-CVI) subgroup.
    • The HD-CVI subgroup demonstrated the best treatment outcome (overall log rank p=0.02 vs SD-IVI).

    Conclusions:

    • High-dose continuous vancomycin infusion (HD-CVI) appears superior for treating osteomyelitis.
    • HD-CVI offers improved patient outcomes compared to standard-dose intermittent vancomycin infusion (SD-IVI).
    • HD-CVI is associated with a reduced incidence of adverse drug reactions, particularly acute renal failure.